ABS Global, a division of Genus plc (GNS:LSE), a global pioneer in animal genetics, today announces a joint venture with De-Su Holsteins, North America’s leading independent breeder of high NM$ (net merit dollars) and TPI® (total performance index) Holstein bulls.
The partnership, which builds on years of effective collaboration between the organizations, will develop elite and differentiated Holstein genetics for ABS Global customers around the world.
The joint venture is named “De Novo Genetics” to signal a new opportunity for the improvement of global Holstein genetics. The De Novo Genetics team will develop a joint breeding program to combine the best genetics from both De-Su and ABS Global, focusing on the creation of elite and differentiated Holstein genetics to help increase customer profitability through improved herd productivity, health and efficiency.
“De Novo Genetics will harness the best Holstein genetics from both companies to create the genetic improvement that our customers need and want, faster than ever before,” said Saskia Korink, ABS Global COO. “We are delighted to be strengthening our long-standing partnership with De-Su and in turn to be expanding our customer offering.”
ABS Global and De-Su – a family operation based in New Albin, Iowa, U.S.A. – have worked together for a number of years. Both organizations share a breeding philosophy of building on traits of economic importance to customers.
“I am excited to blend De-Su’s rich history of genetics with ABS’s genetic portfolio,” said Darin Meyer, De-Su president. “Their commitment to enhancing dairymen’s profits through research and genetic selection is going to be a great foundation for a collaborative focus on science-based genetic development.”